Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Docetaxel enhances CD3+ CD56+ cytokine-induced killer cells-mediated killing through inducing tumor cells phenotype modulation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Feb 2015

Wang WenJia, Qin SiHao, Zhao Lei

Abstract excerpt

Pretreatment with chemotherapeutic agents could sensitize human lung adenocarcinoma cells to the lyses of cytokine-induced killer (CIK) cells, however, the mechanism still unclear. We hypothesized that chemotherapeutic agents could induced immunogenic modulation (IM) and calreticulin (CRT) expression and enhanced the cytokine-induced killer (CIK) cells-mediated killing. Here, using docetaxel, one of the most...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calreticulin
Share to CD3 Complex
Share to CD56 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytotoxicity, Immunologic

Share to Docetaxel

Share to Intercellular Adhesion Molecule-1

Share to Taxoids

Share to Up-Regulation

Source

Identifiers

PMID: 25661332
DOI: 10.1016/j.biopha.2014.10.026

Genes

HMGB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Docetaxel enhances CD3+ CD56+ cytokine-induced killer cells-mediated killing through inducing tumor cells phenotype modulation.PMID 25661332Read ↗

Radiation‐Induced Immunogenic Cell Death for Cancer RadioimmunotherapySemantic proximity Read ↗

Immunogenic chemotherapy effectively inhibits KRAS-Driven lung cancer.Semantic proximity Read ↗

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Semantic proximity Read ↗

Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hotSemantic proximity Read ↗

Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer.Semantic proximity Read ↗

Cancer immunology.Semantic proximity Read ↗

Comparative investigation of the effects of specific antigen‑sensitized DC‑CIK and DC‑CTL cells against B16 melanoma tumor cells.Semantic proximity Read ↗

Towards the Development of Next-Generation Lung Cancer ImmunotherapySemantic proximity Read ↗

Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.Semantic proximity Read ↗

Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer.Semantic proximity Read ↗

Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma.Semantic proximity Read ↗

Biological activity of cytotoxic dendritic cells cocultured with cytokine-induced killer cells and their effect on acute leukemia cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.